Second line systemic therapy options for advanced hepatocellular carcinoma; a systematic review
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
http://www.tandfonline.com/doi/pdf/10.1586/14737140.2015.978295
Reference39 articles.
1. Global Cancer Statistics, 2002
2. Incidence of Hepatocellular Carcinoma in Texas Latinos, 1995–2010: An Update
3. Management of hepatocellular carcinoma
4. Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
5. Hepatocellular carcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. VIRAL HEPATITIS, TOBACCO AND ALCOHOL USE AND RISK OF LIVER CANCER IN THE EASTERN MEDITERRANEAN REGION (EMRO) COUNTRIES: A SYSTEMATIC REVIEW AND META-ANALYSIS;WORLD CANCER RES J;2023
2. Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2;Bioscience Reports;2018-11-09
3. Microarray analysis of altered long non-coding RNA expression profile in liver cancer cells treated by ginsenoside Rh2;Journal of Asian Natural Products Research;2018-11-04
4. The Expanding Role of Systemic Therapy in the Management of Hepatocellular Carcinoma;Canadian Journal of Gastroenterology and Hepatology;2018-08-07
5. Serum mir-30e and mir-223 as novel noninvasive biomarkers for hepatocellular carcinoma;The Scientific Journal of Al-Azhar Medical Faculty, Girls;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3